Completed PHASE2 INTERVENTIONAL 1-arm NCT03104283

Apatinib for the Elderly Advanced Gastric Cancer

A Multicenter, Single-arm, Phase Ⅱ Clinical Trial of Apatinib Monotherapy in Elderly Patients With Advanced Gastric Cancer(GC)

Sponsor: Affiliated Hospital of Qinghai University

Conditions Gastric Cancer

Interventions Apatinib

Updated 9 times since 2017 Last updated: Mar 14, 2022 Started: Jun 5, 2017 Primary completion: Dec 1, 2019 Completion: Jun 2, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Gastric Cancer and is currently completed. Affiliated Hospital of Qinghai University leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Sep 2021 — Apr 2022 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jan 2021 — Sep 2021 [monthly]

Recruiting PHASE2

▶ Show 4 earlier versions

Aug 2019 — Jan 2021 [monthly]

Recruiting PHASE2
Jun 2018 — Aug 2019 [monthly]

Recruiting PHASE2
Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
May 2017 — Sep 2017 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Affiliated Hospital of Qinghai University

Data source: Affiliated Hospital of Qinghai University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xining, China
• Yangquan, China